ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTORITY, PUBLISHED IN APPLICATION OF ARTICLE 34, § 2, PARAGRAPH 3, OF THE LAW OF 2 AUGUST 2002
Trading in financial instrument Thrombogenics, ISIN code BE0003846632 on Euronext Brussels is on the request of the issuer suspended from 12:30pm on 15/03/2013 until the publication of a press release.